Abstract: The invention is related to a method of altering the metabolism of a plant by carrying out the steps of treating seeds of the plant with non-genetically engineered selected mutant pink-pigmented facultative methylotroph having a plant altering capability, and growing the plants from the treated seeds, wherein the plants that grow from such treated seeds exhibit an altered characteristic relative to non-treated plants.
Type:
Grant
Filed:
February 6, 2006
Date of Patent:
April 10, 2012
Assignees:
Salisbury University, The Curators of the University of Missouri
Abstract: The invention relates to a novel bacteriophage which is lytic for species of the genus Methylobacterium, Human Blood Bacterium (HBB) or both, and derivatives, progeny and recombinant and mutated forms thereof. The invention further relates to compositions, methods and kits for using the bacteriophage of the invention in agricultural and therapeutic settings.
Abstract: The present invention relates to improved methods for achieving the synthesis of 1,7-diaryl-1,6-heptadiene-3,5-diones, and in particular curcumin and its analogues. The invention provides a process for synthesizing such compounds in substantial yield and purity using environmentally benign processes and materials. The invention also relates to the use of such synthesized products in the treatment of Alzheimer's Disease and other diseases.
Type:
Grant
Filed:
July 24, 2007
Date of Patent:
March 24, 2009
Assignee:
Salisbury University
Inventors:
Jeffrey Christopher Miller, Miguel O. Mitchell
Abstract: A method for altering fertility of a plant or modifying its structure is described. The method comprises, in any order, contacting the seed of the plant with Pink-Pigmented Facultative Methylotroph (PPFM) that in the aggregate produces more or less amount of cytokinin than the PPFM that was previously associated with the plant, and then planting the seed.
© 2025 Justia
